The purpose of this study is to determine the prevalence in Belgium of Fabry disease in patients with unexplained hypertrophic cardiomyopathy measured by echocardiography and to determine in Fabry patients which was the most frequently initial symptom. Actually the early diagnosis is important because a treatment exists that can prevent future complications.
Study Type
OBSERVATIONAL
Enrollment
120
CHU Dinant-Godinne
Yvoir, Belgium
Percentage of patients with left ventricular hypertrophy who have Fabry Disease mutation
Time frame: 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.